Status:
UNKNOWN
Los Angeles Prospective GI Biliary and EUS Series
Lead Sponsor:
University of Southern California
Conditions:
Biliary Disease
Pancreatitis
Eligibility:
All Genders
Brief Summary
Endoscopic retrograde cholangiopancreatography and endoscopic ultrasound are increasingly being used to manage complex disease of the bile duct, pancreas and cancer. Gastroenterology patients at the L...
Detailed Description
AIMS A) Characterize unusual disease and pathologic presentations which require endoscopic treatment in a large safety net hospital B) To study the impact of EUS and ERCP on the management of these pa...
Eligibility Criteria
Inclusion
- All patients undergoing EUS or ERCP at LAC, UH, and Norris Cancer Hospitals as standard of clinical care will be enrolled.
Exclusion
- None of the patients will be excluded.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT02196935
Start Date
September 1 2010
End Date
December 1 2025
Last Update
June 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Angeles County Hospital
Los Angeles, California, United States, 91030